Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?

Muscle and Nerve

Volumn 49, Issue 1, 2014, Pages 30-34

  Decroos, Emily Choi ^a   Hobson Webb, Lisa D ^a   Juel, Vern C ^a   Massey, Janice M ^a   Sanders, Donald B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acetylcholine receptor antibody; Myasthenia gravis predictive value; Striated muscle antibody; Thymoma

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; MUSCLE ANTIBODY; STRIATED MUSCLE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; BINDING AFFINITY; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; ONSET AGE; PREDICTIVE VALUE; PRIORITY JOURNAL; SKELETAL MUSCLE; THYMOMA; THYMUS;

ACETYLCHOLINE RECEPTOR ANTIBODY; MYASTHENIA GRAVIS PREDICTIVE VALUE; STRIATED MUSCLE ANTIBODY; THYMOMA;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIBODIES; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MUSCLE, STRIATED; MYASTHENIA GRAVIS; RECEPTORS, CHOLINERGIC; RETROSPECTIVE STUDIES; THYMOMA; THYMUS NEOPLASMS; YOUNG ADULT;

EID: 84890429150     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23882     Document Type: Article

References (23)

1. Husain AM, Massey JM, Howard JF, Sanders DB. Acetylcholine receptor antibody measurements in acquired myasthenia gravis. Diagnostic sensitivity and predictive value for thymoma. Ann NY Acad Sci 1998;841:471-474.
2. Vernino S, Lennon VA. Muscle and neuronal autoantibody markers of thymoma: neurological correlations. Ann NY Acad Sci 2003;998:359-361.
3. Vernino S, Lennon VA. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 2004;10:7270-7275.
4. Romi F, Skeie GO, Aarli JA, Gilhus NE. Muscle autoantibodies in subgroups of myasthenia gravis patients. J Neurol 2000;247:369-375.
5. Mygland A, Aarli JA, Matre R, Gilhus NE. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis. J Neurol Neurosurg Psychiatry 1994;57:843-846.
6. Yamamoto AM, Gajdos P, Eymard B, Tranchant C, Warter JM, Gomez L, et al. Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Arch Neurol 2001;58:885-890.
7. Romi F. Thymoma in myasthenia gravis: from diagnosis to treatment. Autoimmune Dis 2011:474-512.
8. Baggi F, Andreetta F, Antozzi C, Simoncini O, Confalonieri P, Labeit S, et al. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma. Ann NY Acad Sci 1998;841:538-541.
9. Chen XJ, Qiao J, Xiao BG, Lu CZ. The significance of titin antibodies in myasthenia gravis-correlation with thymoma and severity of myasthenia gravis. J Neurol 2004;251:1006-1011.
10. Peers J, McDonald BL, Dawkins RL. The reactivity of the antistriational antibodies associated with thymoma and myasthenia gravis. Clin Exp Immunol 1977;27:66-73.
11. Aarli JA, Stefansson K, Marton LS, Wollmann RL. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin Exp Immunol 1990;82:284-288.
12. http://www.mayomedicallaboratories.com/test-catalog/Performance/83370.
13. http://www.mayomedicallaboratories.com/test-catalog/Performance/8746.
14. http://www.mayomedicallaboratories.com/test-catalog/Performance/8338.
15. Kirchner T, Hoppe F, Muller-Hermelink HK, Schalke B, Tzartos S. Acetylcholine receptor epitopes on epithelial cells of thymoma in myasthenia gravis. Lancet 1987;1:218.
16. Maggi L, Andreetta F, Antozzi C, Confalonieri P, Cornelio F, Scaioli V, et al. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor. Neuromuscul Disord 2008;18:678-680.
17. Rigamonti A, Lauria G, Piamarta F, Fiumani A, Agostoni E. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies. J Neurol Sci 2011;302:112-113.
18. Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012;380:499-505.
19. Meer AB, Basu PA, Baker LC, Atlas SW. Exposure to ionizing radiation and estimate of secondary cancers in the era of high-speed CT scanning: projections from the Medicare population. J Am Coll Radiol 2012;9:245-250.
20. Lanska DJ. Diagnosis of thymoma in myasthenics using anti-striated muscle antibodies: predictive value and gain in diagnostic certainty. Neurology 1991;41:520-524.
21. McKeon A, Lennon VA, Lachance DH, Klein CJ, Pittock SJ. Striational antibodies in a paraneoplastic context. Muscle Nerve 2013;47:585-587.
22. Mygland A, Tysnes OB, Matre R, Volpe P, Aarli JA, Gilhus NE. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Ann Neurol 1992;32:589-591.
23. Williams CL, Hay JE, Huiatt TW, Lennon VA. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin. Lab Invest 1992;66:331-336.